---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-018932"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2023-05-24T23:59:59+00:00"
generated_at: "2026-06-14T16:52:32.795913+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical closes $2.66M registered direct offering of common stock and warrants at $2.20/share

## Summary
- Sold 975,000 shares at $2.20 and 234,500 pre-funded warrants at $2.1999, raising ~$2.66M gross.
- Net proceeds to fund LIBERTY Robotic System development, commercialization, regulatory activities, and working capital.
- Amended prior warrants: exercise price reduced to $2.20; 1,022,495 Series B warrants extended to Oct 25, 2027.
- H.C. Wainwright served as placement agent; received 7% cash fee plus 60,475 warrants at $2.75 exercise price.

## SEC filing metadata
- accession: 0001493152-23-018932
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2023-05-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 3.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315223018932/0001493152-23-018932-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315223018932/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-018932
- JSON: https://secwatch.observer/filing/0001493152-23-018932.json
- Plain text: https://secwatch.observer/filing/0001493152-23-018932.txt

## Key facts
- Material Agreements
  Microbot Medical Inc. entered into Engagement Letter with H.C. Wainwright & Co., LLC (effective 2023-05-16).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: H.C. Wainwright & Co., LLC
  - Effective: 2023-05-16
  source text: On May 16, 2023 and in connection with the Offering, the Company entered into an engagement letter (the “Engagement Letter”) with H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which Wainwright agreed to serve as the exclusive placement agent for the issuance and sale of securities of the Company pursuant to the Purchase Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/883975/000149315223018932/0001493152-23-018932-index.htm
- Material Agreements
  Microbot Medical Inc. amended Warrant Amendment Agreement with the Investor.
  - Action: amendment
  - Counterparty: the Investor
  source text: In connection with the Offering, the Company also entered into a warrant amendment agreement (the “Warrant Amendment Agreement”) with the Investor.
  evidence_url: https://www.sec.gov/Archives/edgar/data/883975/000149315223018932/0001493152-23-018932-index.htm
- Material Agreements
  Microbot Medical Inc. entered into Purchase Agreement with an institutional investor valued at approximately $2.66 million (effective 2023-05-23).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: an institutional investor
  - Value: approximately $2.66 million
  - Effective: 2023-05-23
  source text: On May 23, 2023, Microbot Medical Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”), pursuant to which the Company agreed to issue and sell, in a registered direct offering priced at-the-market under the rules of The Nasdaq Stock Market (the “Offering”), (i) an aggregate of 975,000 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”), at an offering price of $2.20 per share and (ii) pre-funded warrants exercisable for up to 234,500 shares of Common Stock (the “Pre-Funded Warrants”) to the Investor at an offering price of $2.1999 per Pre-Funded Warrant, for aggregate gross proceeds from the Offering of approximately $2.66 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/883975/000149315223018932/0001493152-23-018932-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.